missing translation for 'onlineSavingsMsg'
Learn More

Gibco™ CTS™ NK-Xpander™ Medium

CTS NK-Xpander Medium is specifically formulated for superior expansion of human natural killer (hNK) cells for cell therapy applications.

$371.00 - $13500.00

Spécifications

Cell Type Natural Killer (NK) cells
Form Liquid
Serum Level Serum-free
Sterility Sterile-filtered
For Use With (Application) Cell and Gene Therapy Research, Development, and Manufacturing
voir les spécifications

Produits 5
Numéro de catalogue Numéro du manufacturier. Quantity Format Prix Quantité  
Numéro de catalogue Numéro du manufacturier. Quantity Format Prix Quantité  
A5019001
Afficher les documents
Gibco™
A5019001
500 mL Bottle
chaque for $371.00
Il en reste null
 
A5019002
Afficher les documents
Gibco™
A5019002
5 L BPC
chaque for $4,470.00
Il en reste null
 
A5019005
Afficher les documents
Gibco™
A5019005
5 L BPC, Bagged Supplement (100 mL)
chaque for $3,753.00
Il en reste null
 
A5019003
Afficher les documents
Gibco™
A5019003
10 L BPC
chaque for $7,128.00
Il en reste null
 
A5019004
Afficher les documents
Gibco™
A5019004
20 L BPC N/A
N/A
Pour de laide SVP utiliser la function de clavardage; nous envoyer un couriel à help@thermofisher.com ou appelez le service à la clientèle au 1-800-234-7437.
Description

Description

Gibco CTS NK-Xpander Medium is specifically formulated for superior expansion of human natural killer (hNK) cells for cell therapy applications. When hNK cells are enriched from human peripheral blood mononuclear cells (hPBMCs) and expanded in a feeder-free system using CTS NK-Xpander Medium supplemented with 5% hAB serum and 500U/mL IL-2, ≥90% of the hNK cells generated maintain CD56+/CD16+/CD3- surface marker expression. Furthermore, such hNK cells demonstrate degranulation and killing of K562 cancer cells when expanded in CTS NK-Xpander Medium.

Superior expansion potential

CTS NK-Xpander Medium is capable of producing a high yield of hNK cells without the need for feeder cells, providing robust expansion of enriched hNK cells from hPBMCs from qualified donors at day 14 to 15 versus other medium options. Cells maintain CD56+/CD16+/CD3- surface marker expression and demonstrate cytolytic capabilities when expanded in CTS NK-Xpander Medium.

Manufactured for cell therapy applications

CTS NK-Xpander Medium is manufactured without cytokines and growth factors to allow flexibility with regard to intended application. The medium does not include human or animal-derived components; however, supplementation with hAB serum is recommended for best results.

CTS quality

Gibco CTS products follow USP <1043> ancillary materials for cell, gene, and tissue-engineered products within the responsibilities applicable to a supplier.* Documentation such as specific intended-use statements, full documentation traceability, and convenient access to our Drug Master File (DMF) are available to support your regulatory filing.

The products are manufactured at a site that uses methods and controls that conform to cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing sites are ISO 13485-certified.

Closed-system compatibility

CTS NK-Xpander Medium is available in 500-mL-bottle and 5-L-bag formats for convenient process development and closed-system manufacturing scale-up. The 5-L bioprocess container chamber is constructed from Aegis 5-14 film and includes sterile, weldable DEHP-free PVC tubing with Luer lock and C-Flex™ tubing with MPC quick connector providing versatile connection options for your manufacturing process, including compatibility with the CTS Rotea Counterflow Centrifugation System.

*Other aspects of USP <1043> will be the responsibility of the end-user to assess. Thermo Fisher Scientific cannot fulfill USP <1043> in regards to application and therapy-specific aspects (e.g., residual assessment and removal of the AM).

Spécifications

Spécifications

Natural Killer (NK) cells
Serum-free
Cell and Gene Therapy Research, Development, and Manufacturing
Basal: Ambient, Supplement: Dry Ice
Liquid
Sterile-filtered
ISO 13485, MDSAP, FDA-registered, 21 CFR 820
Videos
FDS
Documents

Documents

For Research Use or Manufacturing of Cell, Gene, or Tissue- Based Products. CAUTION: Not intended for direct administration into humans or animals.